Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association of BDNF, HTR2A, TPH1, SLC6A4, and COMT polymorphisms with tDCS and escitalopram efficacy: ancillary analysis of a double-blind, placebo-controlled trial
André R. Brunoni, Ángel Carracedo, Olalla Maroñas, et al.
Brazilian Journal of Psychiatry (2019) Vol. 42, Iss. 2, pp. 128-135
Open Access | Times Cited: 25

Showing 25 citing articles:

The Role of Pharmacogenetics in Personalizing the Antidepressant and Anxiolytic Therapy
Milica Radosavljević, Dubravka Švob Štrac, Jasna Jančić, et al.
Genes (2023) Vol. 14, Iss. 5, pp. 1095-1095
Open Access | Times Cited: 23
Relative synonymous codon usage and codon pair analysis of depression associated genes
Rekha Khandia, Pankaj Gurjar, Mohammad Amjad Kamal, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 11
The association of brain-derived neurotrophic factor with the diagnosis and treatment response in depression
Matea Nikolac Perković, Martin Gredičak, Marina Šagud, et al.
Expert Review of Molecular Diagnostics (2023) Vol. 23, Iss. 4, pp. 283-296
Closed Access | Times Cited: 11
Polymorphisms in genes related to the hypothalamic-pituitary-adrenal axis and antidepressant response – Systematic review
Susanne Fischer, Elena Gardini, Florence Haas, et al.
Neuroscience & Biobehavioral Reviews (2018) Vol. 96, pp. 182-196
Open Access | Times Cited: 18
Effect of Catechol-O-Methyltransferase Genotype Polymorphism on Neurological and Psychiatric Disorders: Progressing Towards Personalized Medicine
Kosha Srivastava, Olive Ochuba, Jasmine K Sandhu, et al.
Cureus (2021)
Open Access | Times Cited: 13
Associations between the 1438A/G, 102T/C, and rs7997012G/A polymorphisms of HTR2A and the safety and efficacy of antidepressants in depression: a meta-analysis
Yuansheng Wan, Xuejia Zhai, Hong-ai Tan, et al.
The Pharmacogenomics Journal (2020) Vol. 21, Iss. 2, pp. 200-215
Closed Access | Times Cited: 14
Application of Transcranial Direct and Alternating Current Stimulation (tDCS and tACS) on Major Depressive Disorder
Seung‐Hoon Lee, Yong‐Ku Kim
Advances in experimental medicine and biology (2024), pp. 129-143
Closed Access | Times Cited: 1
BDNF-related mutations in major depressive disorder: a systematic review
Johannes Hartig, B. Nemeş
Acta Neuropsychiatrica (2022) Vol. 35, Iss. 1, pp. 5-26
Closed Access | Times Cited: 7
Pharmacogenomic and pharmacometabolomic biomarkers of the efficacy and safety of antidepressants: focus on selective serotonin reuptake inhibitors
А. Э. Гареева, Liliya Borodina, S A Pozdnyakov, et al.
S S Korsakov Journal of Neurology and Psychiatry (2024) Vol. 124, Iss. 6, pp. 26-26
Closed Access | Times Cited: 1
BDNF Genetic Variant and Its Genotypic Fluctuation in Major Depressive Disorder
Caroline Ferreira Fratelli, Jhon Willatan Saraiva Siqueira, Bruna Rodrigues Gontijo, et al.
Behavioural Neurology (2021) Vol. 2021, pp. 1-16
Open Access | Times Cited: 8
Polymorphisms of COMT and CREB1 are associated with treatment-resistant depression in a Chinese Han population
Yuting Wang, Shen Li, Lichao Niu, et al.
Journal of Neural Transmission (2021) Vol. 129, Iss. 1, pp. 85-93
Closed Access | Times Cited: 8
Associative gene networks reveal novel candidates important for ADHD and dyslexia comorbidity
HE Hongyao, Ji‐Won Chun, Xiaoyan Gao, et al.
BMC Medical Genomics (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Interactions between tDCS treatment and COMT Val158Met in poststroke cognitive impairment
Yinan Ai, Yuanwen Liu, Mingyu Yin, et al.
Clinical Neurophysiology (2023) Vol. 158, pp. 43-55
Open Access | Times Cited: 3
DNA Methylation Patterns in Relation to Acute Severity and Duration of Anxiety and Depression
Eva Vidovič, S. Pelikán, Marija Atanasova, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 9, pp. 7286-7303
Open Access | Times Cited: 2
Association between genetic polymorphism and antidepressants in major depression: a network meta-analysis
Dan Du, Qiong Tang, Qiong Han, et al.
Pharmacogenomics (2020) Vol. 21, Iss. 13, pp. 963-974
Closed Access | Times Cited: 5
Exploring the Role of Alcohol Metabolizing Genotypes in a 12-Week Clinical Trial of Naltrexone for Alcohol Use Disorder
João Maurício Castaldelli-Maia, André Malbergier, ADRIANA BORGES OLIVEIRA, et al.
Biomolecules (2021) Vol. 11, Iss. 10, pp. 1495-1495
Open Access | Times Cited: 5
SLC6A4 polymorphisms modulate the efficacy of a tryptophan-enriched diet on age-related depression and social cognition
Lierni Ugartemendia, Rafael Bravo, Martin Reuter, et al.
Clinical Nutrition (2021) Vol. 40, Iss. 4, pp. 1487-1494
Closed Access | Times Cited: 4
Perspectives for the application of neurogenetic research in programming Neurorehabilitation
Bartosz Bagrowski
Molecular Aspects of Medicine (2022) Vol. 91, pp. 101149-101149
Open Access | Times Cited: 3
Which can Predict the Outcome of Antidepressants: Metabolic Genes or Pharmacodynamic Genes?
Nan Zheng, Mengxi Niu, Yannan Zang, et al.
Current Drug Metabolism (2023) Vol. 24, Iss. 7, pp. 525-535
Closed Access | Times Cited: 1
Genetic variants used as predictors of response in the pharmacological treatment of depression in the brazilian population
Jéssica da Silva Santos, Pedro Augusto Silva dos Santos Rodrigues, Davi Dias Souza, et al.
Brazilian Journal of Health Review (2023) Vol. 6, Iss. 6, pp. 30109-30122
Open Access | Times Cited: 1
MALDI-TOF MS-based SNP assay used to determine the appropriate antidepression for Chinese patients
Zi Zhang, Zhihao Guo, Tongying Gan, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 252, pp. 116460-116460
Closed Access
Pharmacogenomic and Pharmacometabolomic Biomarkers of the Efficacy and Safety of Antidepressants: Focus on Selective Serotonin Reuptake Inhibitors
А. Э. Гареева, Liliya Borodina, S A Pozdnyakov, et al.
Neuroscience and Behavioral Physiology (2024)
Closed Access
Estudo randomizado, fase II, duplamente coberto, de estimulação elétrica bilateral subcutânea do nervo trigêmeo para o tratamento de depressão maior unipolar - TREND
Alessandra Gorgulho
(2022)
Open Access
Genetics of nonpharmacological treatments of depression
Raffaella Zanardi, Matteo Carminati, Francesco Attanasio, et al.
Psychiatric Genetics (2022) Vol. 33, Iss. 1, pp. 1-7
Closed Access
Mood Disorders: Predictors of tDCS Response
Gerrit Burkhardt, Stephan Goerigk, Frank Padberg
Springer eBooks (2021), pp. 481-490
Closed Access
Page 1

Scroll to top